Exalenz Bioscience Ltd. has reported the appointment of Larry Cohen as the company's CEO. His recent positions, he was the CEO of the HEMOSENSE and President of International Technidyne Corp.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- ILa | -.--% | +1.39% | +107.88% |
1st Jan change | Capi. | |
---|---|---|
+107.88% | 45.97M | |
-6.21% | 180B | |
-0.08% | 108B | |
-3.09% | 68.29B | |
-4.84% | 46.96B | |
+12.85% | 45.64B | |
+7.29% | 42.41B | |
+19.71% | 31.01B | |
+16.53% | 25.51B | |
-7.44% | 23.17B |
- Stock Market
- Equities
- EXEN Stock
- News Exalenz Bioscience Ltd
- Exalenz Bioscience Ltd Appoints Larry Cohen as CEO